Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
674.00    -11.00 (-1.61%)
Bid:
674.00
Ask:
676.00
Spread: 2.00 (0.297%)
Market Cap: £654.60m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Interim Management Statement

23 Jan 2009 07:00

RNS Number : 1292M
Acal PLC
23 January 2009
 



FOR RELEASE

7.00 AM

23 JANUARY 2009

ACAL plc 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1 OCTOBER 2008

Acal plc is today issuing its second Interim Management Statement for the year ending 31 March 2009, which covers the period commencing 1 October 2008 to date and includes trading for the nine months ended 31 December 2008.

Current trading

As we have reported in earlier statements, our markets have become increasingly difficult over the last six months.

Although the Group's sales for the quarter ended 31 December 2008 were slightly ahead of the corresponding quarter to December 2007, margins within the Electronics Division were adversely impacted by the decline in sterling over the quarter.  Within the Supply Chain Division (formerly Parts Services), the new management team has commenced the integration of Service Source Europe and is working to resolve ongoing contract operating losses.

In light of current trading levels, one-off foreign exchange losses and the cost of implementing further efficiencies, the Group result for the year ending 31 March 2009 will be below market expectations.

Following the net benefit from the sale of MessageLabs Group and the acquisition of Service Source Europe Limited, the group retains significant net cash despite increasing pressures on working capital. 

With the appointment of Nick Jefferies as Group Chief Executive on 5 January 2009, we will be carrying out a comprehensive review of Acal's business and strategy. The Board remains confident in the opportunities for the development of the business.

The following material events or transactionseach of which has been previously reported, impacted the Group during the period covered by this Interim Management Statement.

MessageLabs Group Limited

The sale of MessageLabs Group Limited to Symantec was completed on 14 November 2008. The total consideration receivable by Acal for its 3.95% investment is £16.2 million of which £15.1 million was received on that date. The balance is retained in escrow and will be returned to Acal if there are no warranty claims within a 12 month period.

Service Source Europe Limited

The acquisition of 75% of Service Source Europe Limited (SSE) was completed on January 9 2009 for a consideration in cash of £1.85 million. In addition, Acal subscribed for deferred shares in SSE with a total nominal value of £346,625 in cash to enable SSE's preference shares to be redeemed.

  

For further information:-

Nicholas Jefferies ~ Chief Executive

Malcolm Cooper ~ Finance Director

Brian Coleman-Smith/James Verstringhe

Cubitt Consulting 

01483 544500

01483 544500

020 7367 5100

Notes to the Interim Management Statement

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority’s Disclosure and Transparency Rules.
 
(b) The Interim Management Statement may contain forward-looking statements which:

 

§ have been made by the directors in good faith based on the information available to them up to the time of their approval of this statement; and
 
§ should be treated with caution due to inherent uncertainties, which are beyond Acal’s ability to control or estimate precisely and include both economic and business risk factors, underlying such forward looking information.

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components, Supply Chain Services and Medical and Scientific products. Organised into three divisions, Acal has 15 principal trading companies of which 8 are in Continental Europe and 7 in the UK.

Acal is now Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both the UK and South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. The Supply Chain division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBCGDBXGDGGCD
Date   Source Headline
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report
17th Oct 20187:00 amRNSAcquisition
11th Oct 20187:00 amRNSTrading Update
10th Sep 20183:17 pmRNSIssue of Equity
22nd Aug 201811:30 amRNSHolding(s) in Company
26th Jul 20182:45 pmRNSResult of General Meeting
26th Jul 20182:40 pmRNSResult of AGM
26th Jul 20187:00 amRNSTrading Update
11th Jul 20182:17 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPublication of Circular and Notice of EGM
26th Jun 20184:46 pmRNSAnnual Report and Accounts
19th Jun 20183:03 pmRNSIssue of Equity
11th Jun 201810:56 amRNSHolding(s) in Company
7th Jun 20184:08 pmRNSDirector/PDMR Shareholding
6th Jun 20189:00 amRNSExercise of share options
5th Jun 20187:00 amRNSFinal Results
19th Apr 20187:00 amRNSTrading Update
29th Mar 20182:15 pmRNSDirector/PDMR Shareholding
27th Mar 20182:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.